322 related articles for article (PubMed ID: 18253929)
21. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells.
Fischer K; Scotet E; Niemeyer M; Koebernick H; Zerrahn J; Maillet S; Hurwitz R; Kursar M; Bonneville M; Kaufmann SH; Schaible UE
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10685-90. PubMed ID: 15243159
[TBL] [Abstract][Full Text] [Related]
22. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells.
Eberl G; MacDonald HR
Eur J Immunol; 2000 Apr; 30(4):985-92. PubMed ID: 10760785
[TBL] [Abstract][Full Text] [Related]
23. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
[TBL] [Abstract][Full Text] [Related]
24. IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses.
Moreno M; Molling JW; von Mensdorff-Pouilly S; Verheijen RH; Hooijberg E; Kramer D; Reurs AW; van den Eertwegh AJ; von Blomberg BM; Scheper RJ; Bontkes HJ
J Immunol; 2008 Aug; 181(4):2446-54. PubMed ID: 18684935
[TBL] [Abstract][Full Text] [Related]
25. CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4.
Ueda N; Kuki H; Kamimura D; Sawa S; Seino K; Tashiro T; Fushuku K; Taniguchi M; Hirano T; Murakami M
Int Immunol; 2006 Sep; 18(9):1397-404. PubMed ID: 16914507
[TBL] [Abstract][Full Text] [Related]
26. CD1d-mediated antigen presentation to natural killer T (NKT) cells.
Brutkiewicz RR; Lin Y; Cho S; Hwang YK; Sriram V; Roberts TJ
Crit Rev Immunol; 2003; 23(5-6):403-19. PubMed ID: 15030309
[TBL] [Abstract][Full Text] [Related]
27. CD1 antigen presentation by human dendritic cells as a target for herpes simplex virus immune evasion.
Raftery MJ; Winau F; Kaufmann SH; Schaible UE; Schönrich G
J Immunol; 2006 Nov; 177(9):6207-14. PubMed ID: 17056550
[TBL] [Abstract][Full Text] [Related]
28. Cutting edge: analysis of human V alpha 24+CD8+ NK T cells activated by alpha-galactosylceramide-pulsed monocyte-derived dendritic cells.
Takahashi T; Chiba S; Nieda M; Azuma T; Ishihara S; Shibata Y; Juji T; Hirai H
J Immunol; 2002 Apr; 168(7):3140-4. PubMed ID: 11907064
[TBL] [Abstract][Full Text] [Related]
29. Interplay of cytokines and microbial signals in regulation of CD1d expression and NKT cell activation.
Sköld M; Xiong X; Illarionov PA; Besra GS; Behar SM
J Immunol; 2005 Sep; 175(6):3584-93. PubMed ID: 16148102
[TBL] [Abstract][Full Text] [Related]
30. CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytes.
Fais F; Morabito F; Stelitano C; Callea V; Zanardi S; Scudeletti M; Varese P; Ciccone E; Grossi CE
Int J Cancer; 2004 Apr; 109(3):402-11. PubMed ID: 14961579
[TBL] [Abstract][Full Text] [Related]
31. [A specific ligand of V alpha 14 NKT cells and its presentation].
Harada M; Taniguchi M
Tanpakushitsu Kakusan Koso; 2003 Jun; 48(8 Suppl):1126-32. PubMed ID: 12807019
[No Abstract] [Full Text] [Related]
32. Mediastinal lymph node CD8alpha- DC initiate antigen presentation following intranasal coadministration of alpha-GalCer.
Ko SY; Lee KA; Youn HJ; Kim YJ; Ko HJ; Heo TH; Kweon MN; Kang CY
Eur J Immunol; 2007 Aug; 37(8):2127-37. PubMed ID: 17615581
[TBL] [Abstract][Full Text] [Related]
33. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells.
Sriram V; Du W; Gervay-Hague J; Brutkiewicz RR
Eur J Immunol; 2005 Jun; 35(6):1692-701. PubMed ID: 15915536
[TBL] [Abstract][Full Text] [Related]
34. CD1d-restricted NKT cells contribute to malarial splenomegaly and enhance parasite-specific antibody responses.
Hansen DS; Siomos MA; De Koning-Ward T; Buckingham L; Crabb BS; Schofield L
Eur J Immunol; 2003 Sep; 33(9):2588-98. PubMed ID: 12938235
[TBL] [Abstract][Full Text] [Related]
35. Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells.
Durante-Mangoni E; Wang R; Shaulov A; He Q; Nasser I; Afdhal N; Koziel MJ; Exley MA
J Immunol; 2004 Aug; 173(3):2159-66. PubMed ID: 15265953
[TBL] [Abstract][Full Text] [Related]
36. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide.
Tulley JM; Palmer JL; Gamelli RL; Faunce DE
Shock; 2008 Feb; 29(2):269-77. PubMed ID: 17693934
[TBL] [Abstract][Full Text] [Related]
37. Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells.
Takahashi T; Nieda M; Koezuka Y; Nicol A; Porcelli SA; Ishikawa Y; Tadokoro K; Hirai H; Juji T
J Immunol; 2000 May; 164(9):4458-64. PubMed ID: 10779745
[TBL] [Abstract][Full Text] [Related]
38. CD1d-dependent activation of NKT cells aggravates atherosclerosis.
Tupin E; Nicoletti A; Elhage R; Rudling M; Ljunggren HG; Hansson GK; Berne GP
J Exp Med; 2004 Feb; 199(3):417-22. PubMed ID: 14744994
[TBL] [Abstract][Full Text] [Related]
39. Distinct endosomal trafficking requirements for presentation of autoantigens and exogenous lipids by human CD1d molecules.
Chen X; Wang X; Keaton JM; Reddington F; Illarionov PA; Besra GS; Gumperz JE
J Immunol; 2007 May; 178(10):6181-90. PubMed ID: 17475845
[TBL] [Abstract][Full Text] [Related]
40. Sulfatide inhibits α-galactosylceramide presentation by dendritic cells.
Kanamori M; Tasumi Y; Iyoda T; Ushida M; Inaba K
Int Immunol; 2012 Feb; 24(2):129-36. PubMed ID: 22247226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
